Pharmas active in developing antihypertensive combination drugs
Ever since the incrementally modified drug system was adopted in 2009, total 16 products were approved as a combination therapy for hypertension.
Moreover, antihypertensives are reportedly moving towards a trend with the 3-way combination, ARB, CCB and diuretic.
The Ministry of Food and Drug Sa...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
